|
|
Volumn 24, Issue 12, 2006, Pages 1457-
|
|
Niche indications could drive higher valuations
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMBRISENTAN;
DARUSENTAN;
ENZYME;
BIOTECHNOLOGICAL PRODUCTION;
BIOTECHNOLOGY;
DRUG INDUSTRY;
ENZYME REPLACEMENT;
FABRY DISEASE;
FINANCIAL MANAGEMENT;
GAUCHER DISEASE;
HEALTH CARE POLICY;
HEREDITY;
HUMAN;
INVESTMENT;
MARKETING;
NOTE;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RNA INTERFERENCE;
BIOTECHNOLOGY;
DRUG INDUSTRY;
HUMANS;
INVESTMENTS;
LUNG DISEASES;
|
|
EID: 33845707073
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1206-1457 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
